Lin CC - Search Results

1

Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.

Lin CC, Hsu CH, Huang CY, Keng HY, Tsai YC, Huang KH, Cheng AL, Pu YS. Lin CC, et al. Anticancer Drugs. 2007 Apr;18(4):487-91. doi: 10.1097/CAD.0b013e3280126603. Anticancer Drugs. 2007. PMID: 17351402 Clinical Trial.

2

A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.

Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH. Hsu CH, et al. Among authors: lin cc. Anticancer Res. 2002 Nov-Dec;22(6B):3621-7. Anticancer Res. 2002. PMID: 12552966 Clinical Trial.

3

Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.

Hour TC, Huang CY, Lin CC, Chen J, Guan JY, Lee JM, Pu YS. Hour TC, et al. Among authors: lin cc. Anticancer Drugs. 2004 Sep;15(8):779-85. doi: 10.1097/00001813-200409000-00007. Anticancer Drugs. 2004. PMID: 15494640

4

Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.

Pu YS, Hsieh MW, Wang CW, Liu GY, Huang CY, Lin CC, Guan JY, Lin SR, Hour TC. Pu YS, et al. Among authors: lin cc, lin sr. Biochem Pharmacol. 2006 Mar 14;71(6):751-60. doi: 10.1016/j.bcp.2005.12.009. Epub 2006 Jan 18. Biochem Pharmacol. 2006. PMID: 16413505

5

Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.

Lin CC, Hsu CH, Huang CY, Cheng AL, Chen J, Vogelzang NJ, Pu YS. Lin CC, et al. Cancer. 2006 Mar 15;106(6):1269-75. doi: 10.1002/cncr.21738. Cancer. 2006. PMID: 16470604 Free article. Clinical Trial.

6

Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer.

Hour TC, Pu YS, Lin CC, Huang SW, Chen J, Chiu AW, Chen CJ, Huang CY. Hour TC, et al. Among authors: lin cc. Anticancer Res. 2006 Jan-Feb;26(1A):375-8. Anticancer Res. 2006. PMID: 16475721 Free article.

7

Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case study.

Lin CC, Hsu CH, Pu YS. Lin CC, et al. Anticancer Res. 2006 Jul-Aug;26(4B):3191-5. Anticancer Res. 2006. PMID: 16886656 Free article.

8

Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.

Lin CC, Hsu C, Hsu CH, Hsu WL, Cheng AL, Yang CH. Lin CC, et al. Invest New Drugs. 2007 Feb;25(1):77-84. doi: 10.1007/s10637-006-9004-9. Epub 2006 Aug 26. Invest New Drugs. 2007. PMID: 16937079 Clinical Trial.

9

Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.

Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS. Lin CC, et al. J Urol. 2007 Jan;177(1):84-9; discussion 89. doi: 10.1016/j.juro.2006.08.058. J Urol. 2007. PMID: 17162009 Clinical Trial.

10

A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.

Lin CC, Cheng AL, Hsu CH, Lu YS, Hsu C, Yeh KH, Wu CY, Huang CS, Yang CH. Lin CC, et al. Anticancer Res. 2007 Jan-Feb;27(1B):641-5. Anticancer Res. 2007. PMID: 17348454 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,888 results

Search Page

Filters